Alpha Modus (AMOD) 10-Q 2 Jun 23 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	May 30, 2023
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Registrant Name	Insight Acquisition Corp. /DE
Entity Central Index Key	0001862463
Entity Incorporation, State or Country Code	DE
Entity File Number	001-40775
Entity Tax Identification Number	86-3386030
Entity Address, Address Line One	333 East 91st Street
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10128
City Area Code	917
Local Phone Number	374-2922
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant
Trading Symbol	INAQU
Security Exchange Name	NASDAQ
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	edeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
Trading Symbol	INAQW
Security Exchange Name	NASDAQ
Class A [Member]
Document Information [Line Items]
Title of 12(b) Security	Class A Common Stock, $0.0001 par value
Trading Symbol	INAQ
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		7,948,607
Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		900,000

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 50,931	$ 171,583
Restricted Cash	1,297,608
Prepaid expenses	212,500	367,219
Total current assets	1,561,039	538,802
Investments held in Trust Account	29,211,576	244,314,622
Total Assets	30,772,615	244,853,424
Current liabilities:
Accounts payable	151,013	128,835
Accrued expenses	256,993	68,216
Accrued expenses—related party	160,000	85,000
Income tax payable	1,040,836	467,991
Franchise tax payable	50,000	149,041
Total current liabilities	1,658,842	899,083
Deferred tax liability	0	156,593
Deferred underwriting commissions in connection with the Initial Public Offering	6,600,000	12,000,000
Derivative liabilities	260,840	84,890
Forward Purchase Agreement Liability Non Current	125,473
Total Liabilities	8,645,155	13,140,566
Commitments and Contingencies
Stockholder's Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at March 31, 2023 and December 31, 2022	0	0
Additional paid-in capital	13,631	0
Accumulated deficit	(7,361,712)	(11,885,332)
Total stockholders' deficit	(7,347,481)	(11,884,732)
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders' Deficit	30,772,615	244,853,424
Class A [Member]
Current liabilities:
Class A common stock subject to possible redemption, $0.0001 par value; 2,848,607 and 24,000,000 shares at $10.35 and $10.15 per share redemption value at March 31, 2023 and December 31, 2022, respectively	29,474,941	243,597,590
Stockholder's Deficit:
Common stock	510	0
Class B [Member]
Stockholder's Deficit:
Common stock	$ 90	$ 600

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Class A ordinary shares, shares subject to possible redemption outstanding	2,848,607	24,000,000
Class A ordinary shares, shares subject to possible redemption per share	$ 10.05
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Class A [Member]
Class A ordinary shares, shares subject to possible redemption par value	$ 0.0001	$ 0.0001
Class A ordinary shares, shares subject to possible redemption outstanding	2,848,607	24,000,000
Class A ordinary shares, shares subject to possible redemption per share	$ 10.35	$ 10.15
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	200,000,000	200,000,000
Common stock shares issued	7,948,607	24,000,000
Common stock shares outstanding	7,948,607	24,000,000
Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	20,000,000	20,000,000
Common stock shares issued	900,000	6,000,000
Common stock shares outstanding	900,000	6,000,000
Class A Non Redeemable Shares [Member]
Common stock shares issued	5,100,000	0
Common stock shares outstanding	5,100,000	0

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
General and administrative expenses	$ 506,326	$ 413,077
General and administrative expenses - related party	75,000	0
Franchise tax expenses	50,000	48,817
Loss from operations	(631,326)	(461,894)
Other income (expense):
Change in fair value of derivative warrant liabilities	(175,950)	3,899,070
Change in fair value of Forward Purchase Agreement Liability	(39,104)	0
Gain (Loss) on investments held in Trust Account	1,884,991	(57,679)
Gain on forgiveness of deferred underwriting fee payable	273,110	57,679
Total other income, net	1,943,047	3,841,391
Income before income taxes	1,311,721	3,379,497
Income tax expense	(416,252)	0
Net income	$ 895,469	3,379,497
Weighted average shares outstanding, Basic	5,484,270
Weighted average shares outstanding, Diluted	5,484,270
Basic and diluted net income per common share, Basic	$ 0.04
Basic and diluted net income per common share, Diluted	$ 0.04
Common Class B [Member]
Other income (expense):
Net income	$ 205,133	$ 675,899
Weighted average shares outstanding, Basic	5,484,270	6,000,000
Weighted average shares outstanding, Diluted	5,484,270	6,000,000
Basic and diluted net income per common share, Basic	$ 0.04	$ 0.11
Basic and diluted net income per common share, Diluted	$ 0.04	$ 0.11
Class A Redeemable Shares [Member]
Other income (expense):
Weighted average shares outstanding, Basic	18,456,264	24,000,000
Weighted average shares outstanding, Diluted	18,456,264	24,000,000
Basic and diluted net income per common share, Basic	$ 0.04	$ 0.11
Basic and diluted net income per common share, Diluted	$ 0.04	$ 0.11
Class A Non Redeemable Shares [Member]
Other income (expense):
Weighted average shares outstanding, Basic	1,473,333
Weighted average shares outstanding, Diluted	1,473,333
Basic and diluted net income per common share, Basic	$ 0.04
Basic and diluted net income per common share, Diluted	$ 0.04

Condensed Statements of Changes

Condensed Statements of Changes in Stockholders' Deficit - USD ($)	Total	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Class A [Member]	Class A [Member] Common Stock [Member]	Class B [Member]	Class B [Member] Common Stock [Member]
Beginning balance at Dec. 31, 2021	$ (21,394,576)	$ 0	$ (21,395,266)		$ 0		$ 600
Beginning balance (Shares) at Dec. 31, 2021					0		6,000,000
Net income	3,379,497		3,379,497	$ 2,703,598		$ 675,899
Ending balance at Mar. 31, 2022	(18,015,079)	0	(18,015,769)		$ 0		$ 600
Ending balance (Shares) at Mar. 31, 2022					0		6,000,000
Beginning balance at Dec. 31, 2021	(21,394,576)	0	(21,395,266)		$ 0		$ 600
Beginning balance (Shares) at Dec. 31, 2021					0		6,000,000
Accretion of Class A common stock subject to redemption value				31,230,313
Ending balance at Dec. 31, 2022	(11,884,732)	0	(11,885,332)		$ 0		$ 600
Ending balance (Shares) at Dec. 31, 2022					0		6,000,000
Accretion of Class A common stock subject to redemption value	3,628,151		3,628,151
Contributions from Sponsor	100,000	100,000
Initial Value of Forward Purchased Agreement	(86,369)	(86,369)
Class B common stock converted to Class A common stock on a one for one basis (Shares)					5,100,000		(5,100,000)
Class B common stock converted to Class A common stock on a one for one basis					$ 510		$ (510)
Net income	895,469		895,469	$ 690,336		$ 205,133
Ending balance at Mar. 31, 2023	$ (7,347,481)	$ 13,631	$ (7,361,712)		$ 510		$ 90
Ending balance (Shares) at Mar. 31, 2023					5,100,000		900,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities:
Net income	$ 895,469	$ 3,379,497
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	175,950	(3,899,070)
Change in fair value of Forward Purchase Agreement Liability	39,104	0
(Gain) Loss on investments held in Trust Account	(1,884,991)	57,679
Gain on elimination of deferred underwriting fee	(273,110)	0
Changes in operating assets and liabilities:
Deferred tax provision (benefit)	(156,593)
Prepaid expenses	154,719	69,307
Accounts payable	22,178	85,027
Accrued expenses – related party	188,777	30,800
Due to related party	75,000	0
Income tax payable	572,845	0
Franchise tax payable	(99,041)	53,231
Net cash used in operating activities	(289,693)	(223,529)
Cash Flows from Investing Activities
Cash withdrawn from Trust Account to pay franchise and income taxes	1,446,649	0
Cash withdrawn from Trust Account in connection with redemption	215,621,388	0
Cash deposited in Trust Account	(80,000)	0
Net cash provided by investing activities	216,988,037	0
Cash Flows from Financing Activities:
Contributed from Sponsor	100,000	0
Offering costs paid	0	(85,000)
Redemption of common stock	(215,621,388)	0
Net cash used in financing activities	(215,521,388)	(85,000)
Net change in cash	1,176,956	(308,529)
Cash – beginning of the period	171,583	877,937
Cash – end of the period	1,348,539	569,408
Cash	50,931	569,408
Restricted Cash	1,297,608
Supplemental disclosure of noncash activities:
Accretion for Class A common stock	510	0
Class B converted to Class A on a one for one basis	83,369	0
Deferred underwriting fee payable	$ (5,126,890)	$ 0

Description of Organization and

Description of Organization and Business Operations	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations	Note 1 - Description of Organization and Business Operations Insight Acquisition Corp. (the “Company”) was incorporated in Delaware on April 20, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of March 31, 2023, the Company had not commenced any operations. All activity for the period from April 20, 2021 (inception) through March 31, 2023 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below and subsequent to the Initial Public Offering, the search for a business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating The Company’s sponsor is Insight Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on September 1, 2021. On September 7, 2021, the Company consummated its Initial Public Offering of 24,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $240.0 million, and incurring offering costs of approximately $17.5 million, of which approximately $12.0 million and approximately $668,000 were for deferred underwriting commissions (see Note 5) and offering costs allocated to derivate warrant liabilities, respectively. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 7,500,000 and 1,200,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), to the Sponsor and Cantor Fitzgerald & Co. (“Cantor”) and Odeon Capital Group, LLC (“Odeon”), respectively, for an aggregate of 8,700,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, generating proceeds of $8.7 million (see Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $241.2 million ($10.05 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule2a-7promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes and excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company will provide the holders of the Company’s outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, in its sole discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.05 per Public Share plus pro rata interest earned in Trust Account). The per-share Standards Codification (“ASC”) Topic 480,“Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the holders of 65% of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 3) and any Public Shares purchased during or after the Initial Public Offering, and the Anchor Investors (as defined below in Note 3) agreed to vote any Founder Shares held by them in favor of a Business Combination. In addition, the Initial Stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company. The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and any other holders of the Founder Shares immediately prior to the Initial Public Offering (the “Initial Stockholders”) agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial The Anchor Investors are not entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of the initial Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a stockholder vote to amend the Certificate of Incorporation in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period). If the Company is unable to complete a Business Combination by June 7, 2023 (the “Combination Period”), which may be extended by the board of directors in its sole discretion on a monthly basis up to and including September 7, 2023. If the Company is unable to complete its initial business combination by such date, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share On March 6, 2023 the Company held a special meeting (the “Special Meeting”) of stockholders. At the Special Meeting, the Company’s stockholders were asked to vote on the following items: (i) a proposal to amend the Charter to extend the date by which the Company has to consummate a business combination for an additional one month, from March 7, 2023 to April 7, 2023 and thereafter, at the discretion of the board of directors of the Company and without a vote of the stockholders, up to five (5) times for an additional one month each time, for a total of up to five additional months to September 7, 2023 (the “First Charter Amendment Proposal”), (ii) a proposal to amend the Company’s Charter to eliminate from the Charter the limitation that the Company may not redeem public shares to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) one-for-one remained in the trust account and shares of Class A Common Stock remained issued and outstanding. On March 28, 2023, the board of directors of the Company approved a one-month 2 one-month On March 29, 2023, the Company entered into a forward share purchase agreement (the “Forward Share Purchase Agreement”) with Avila, Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP and Meteora Select Trading Opportunities Master, LP (collectively, “Seller”) for an OTC Equity Prepaid Forward Transaction (the “Forward Purchase Transaction”). Pursuant to the terms of the Forward Purchase Agreement, Seller intends but is not obligated to purchase SPAC Class A Common Stock from holders (other than SPAC or its affiliates) who have elected to redeem such shares in connection with the Proposed Transactions. Purchases by Seller will be made through brokers in the open market after the redemption deadline in connection with the Proposed Transactions at a price no higher than the redemption price to be paid by SPAC in connection with the Proposed Transactions (the “Initial Price”). The Shares purchased by the Seller, other than the Share Consideration Shares are referred to herein as the “Recycled Shares.” The Seller also may sell 2,376,000 shares of SPAC Class A Common Stock purchased in the SPAC’s initial public offering (“IPO Shares”) in the Forward Purchase Transaction, up to a maximum of 2,500,000 shares of Class A Common Stock (including any Recycled Shares). The Initial Stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.05. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed financial statements. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Liquidity and Going Concern As of March 31, 2023, the Company had approximately $1.3 million in its operating bank account and working capital surplus of approximately $59,000. The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on behalf of the Company in exchange for issuance of the Founder Shares (as defined in Note 4), and the loan from the Sponsor of approximately $163,000 under the Note (as defined in Note 4). The Company repaid $157,000 of Note balance on September 7, 2021 and repaid the remaining balance of approximately $6,000 in full on September 13, 2021, at which time the Note was terminated. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). As of March 31, 2023 and December 31, 2022, there were no amounts outstanding under any Working Capital Loans. In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15,

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Note 2 - Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form10-K filed by the Company with the SEC on April 19, 2023. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation cover a Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Use of Estimates The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income from investments held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” equals or approximates the carrying amounts represented in the condensed balance sheets, except for the derivative liabilities (see Note 9). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value Derivative Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants and the forward purchase agreement, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period for so long as they are outstanding. The initial fair value of the Public Warrants issued in connection with the Public Offering and the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using the public market quoted prices at each measurement date starting at June 30, 2022. The fair value of Public Warrants has subsequently been measured based on the listed market price of such warrants. Derivative warrant liabilities are classified as non-current The Company granted the underwriters a 45-day The Forward Purchased Agreement entered into on March 29, 2023 included elements that require liability classification under ASC 480. Accordingly, the Company recognizes the Forward Purchase Agreement as a liability at fair value and adjusts the carrying value of the instruments to fair value at each reporting period for so long as it is outstanding. The initial fair value and the value as of March 31, 2023 of the Forward Purchase Agreement liability issued was estimated using a Put Option Pricing model, which analyzed and incorporated into the model the put price, the risk-free rate, the variable term, the settlement features, the likelihood of completing a business combination and the early termination provisions. The model estimates the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e., stock price, exercise price, etc.). Probabilities were assigned to each variable such as the timing and pricing of events over the term of the instruments based on management projections. The fair value was adjusted for the market implied likelihood of completing a business combination. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating non-current Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were offset by a full valuation allowance as of March 31, 2023 and December 31, 2022. The Deferred tax liability as of March 31, 2023 and December 31, 2022 were zero and $156,593, respectively. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the fin a Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 2,848,607 and 24,000,000 shares of Class A common stock subject to possible redemption as of March 31, 2023 and December 31, 2022, respectively, are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A common stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in Net Income Per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. The presentation assumes a business combination as the most likely outcome. Net income per common share is calculated by dividing the net income by the weighted average shares of common stock outstanding for the respective period. The calculation of diluted net income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the private placement warrants to purchase an aggregate of 20,700,000 shares of Class A common stock in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the three months ended March 31, 2023 and 2022. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of common stock: For the Three Months Ended March 31, 2023 2022 Class A Class B Class A Class B Basic and diluted net income per common share: Numerator: Allocation of net income $ 690,336 $ 205,133 $ 2,703,598 $ 675,899 Denominator: Basic and diluted weighted average common shares outstanding 18,456,264 5,484,270 24,000,000 6,000,000 Basic and diluted net income per common share $ 0.04 $ 0.04 $ 0.11 $ 0.11 Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial stateme n

Initial Public Offering

Initial Public Offering	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Initial Public Offering	Note 3 - Initial Public Offering On September 7, 2021, the Company consummated its Initial Public Offering of 24,000,000 Units, generating gross proceeds of $240.0 million, and incurring offering costs of approximately $17.5 million, of which approximately $12.0 million and approximately $668,000 were for deferred underwriting commissions and offering costs allocated to derivative warrant liabilities, respectively. Each Unit consists of one share of Class A common stock, and one-half m Of the 24,000,000 Units sold in the Initial Public Offering, 23,760,000 Units were purchased by certain qualified institutional buyers or institutional accredited investors which are not affiliated with any member of the Company management (the “Anchor Investors”). In connection with the sale of Units to the Anchor Investors, the Sponsor transferred an aggregate of 1,350,000 of the Company’s Class B common stock held by the Sponsor (the “Founder Shares”) to the Anchor Investors at a price of approximately $0.004 per Founder Share. The Company determined that the excess of the fair value of the Founder Shares acquired by the Anchor Investors over the price paid by such Anchor Investors should be recognized as an offering cost in accordance with SEC Staff Accounting Bulletin Topic 5A. The Company estimated the fair value of the Founder Shares sold to the Anchor Investors to be $2.37 per share or an aggregate of approximately $3.2 million, based on third-party transactions in the Sponsor’s equity interests. Accordingly, the offering cost is allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to the Public Warrants are expensed as incurred. Offering costs allocated to the Public Shares are charged against the carrying value of Class A common stock upon the completion of the Initial Public Offering. The Company granted the underwriters a 45-day un

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 4 - Related Party Transactions Founder Shares On May 5, 2021, the Sponsor paid for certain offering costs totaling $25,000 on behalf of the Company in exchange for issuance of 6,181,250 shares of the Company’s Founder Shares, par value $0.0001 per share. On July 29, 2021, the Company effected a 1:1.1162791 stock split of Class B common stock, resulting in an aggregate of 6,900,000 shares of Class B common stock outstanding. In connection with the sale of Units to the Anchor Investors, the Sponsor transferred 1,350,000 Founder Shares to the Anchor Investors, as described in Note 3, above. The Sponsor agreed to forfeit up to 900,000 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters, so that the Founder Shares will represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On October 16, 2021, the over-allotment option expired unexercised. As such, 900,000 shares of Class B common stock were forfeited. The Initial Stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (i) one year after the completion of the initial Business Combination and (ii) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their common stock for cash, securities or other property. Notwithstanding the foregoing, if the closing price of Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any30-tradingday period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the lockup. Contributed Capital During the quarter ended March 31, 2023, the Sponsor contributed $100,000 to the Company for no consideration. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 7,500,000 and 1,200,000 Private Placement Warrants to the Sponsor and Cantor and Odeon, respectively, for an aggregate of 8,700,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, generating proceeds of $8.7 million. Each Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor and the underwriters was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. Except as set forth below, the Private Placement Warrants will be non-redeemable The Sponsor, the underwriters and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Loans On April 30, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2023 and December 31, 2022, the Company had no borrowings under the Working Capital Loans. Services Agreement On September 1, 2021, the Company entered into an agreement with the Sponsor, pursuant to which the Company agreed to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to or incurred by members of the Company’s management team until the earlier of the Company’s consummation of a Business Combination and the Company’s liquidation. For the three months ended March 31, 2023 and 2022, the Company incurred approximately $30,000 and $30,000, respectively, under the services agreement in the condensed statements of operations. As of March 31, 2023 and December 31, 2022, $30,000 and $40,000 was included in due to related party on the condensed balance sheets, respectively. The board of directors has also approved payments of up to $15,000 per month, through the earlier of the consummation of the Company’s initial Business Combination or its liquidation, to members of the Company’s management team for services rendered to the Company. In addition, the Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5 - Commitments and Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares), were entitled to registration rights pursuant to a registration and stockholder rights agreement signed prior to the consummation of the Initial Public Offering. These holders were entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.8 million in the aggregate, paid upon the closing of the Initial Public Offering. An additional fee of $0.50 per unit, or $12.0 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. If the underwriters’ over-allotment option was fully exercised, $0.70 per over-allotment unit, or up to an additional approximately $2.5 million, or approximately $14.5 million in the aggregate, would have been deposited in the Trust Account as deferred underwriting commissions. On October 16, 2021, the over-allotment option expired unexercised. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On October 16, 2021, the over-allotment option expired unexercised. On March 28, 2023, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to $ of gain on forgiveness of underwriting fee payable and $ towards Class A redeemable shares in relation to the forgiveness of the deferred underwriter fee allocated to the underwriter in the accompanying consolidated financial statements. In connection with this waiver, the underwriter also agreed that the remainder of the deferred underwriting fee of $ Forward Share Purchase Agreement On March 29, 2023, the Company entered into a forward share pur

Class A Shares of Common Stock

Class A Shares of Common Stock Subject to Possible Redemption	3 Months Ended
	Mar. 31, 2023
Temporary Equity Disclosure [Abstract]
Class A Shares of Common Stock Subject to Possible Redemption	Note 6 - Class A Shares of Common Stock Subject to Possible Redemption The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. In connection with the Extension, the holders of 21,151,393 Class A common shares, representing approximately 88.1% of the Company’s issued and outstanding Class A common shares, elected to redeem their shares. Following such redemptions, approximately $28,744,831 will remain in the trust account and 2,848,607 shares of Class A Common Stock subject to possible redemption will remain issued and outstanding. As of March 31, 2023 and December 31, 2022, there were 2,848,607 and 24,000,000 shares of Class A common stock subject to possible redemption outstanding at $10.25 and $10.15 redemption value, respectively, all of which were subject to possible redemption. The shares of Class A common stock issued in the Initial Public Offering were recognized in Class A common stock subject to possible redemption as follows: Gross proceeds from Initial Public Offering $ 240,000,000 Less: Fair value of Public Warrants at issuance (7,582,627 ) Offering costs allocated to Class A common stock subject to possible redemption (20,050,096 ) Plus: Accretion on Class A common stock subject to possible redemption amount 31,230,313 Class A common stock subject to possible redemption at December 31, 2022 243,597,590 Less: Redemptions (215,621,388 ) Accretion of carrying value to redemption value (3,628,151 ) Plus: Waiver of underwriting fee allocated to Class A Common Stock 5,126,890 Class A common stock subject to possible redemption at March 31, 2023 $ 29,474,941

Stockholders' Deficit

Stockholders' Deficit	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Stockholders' Deficit	Note 7 - Stockholders’ Deficit Preferred Stock - Class A Common Stock - 7,948,607 shares of Class A common stock issued and outstanding. All shares of Class A common stock subject to possible redemption have been classified as temporary equity (see Note 6). On March 22, 2023, shares of Class B common stock were exchanged for an equal number of shares of Class A common stock. Such shares are not entitled to redemption rights. Class B Common Stock - Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class B common stock and holders of Class A common stock will vote together as a single class, except as required by applicable law or stock exchange rule. The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial Business Combination on a one-for-one as-converted one-for-one

Warrants

Warrants	3 Months Ended
	Mar. 31, 2023
Warrants [Abstract]
Warrants	Note 8 - Warrants As of March 31, 2023 and December 31, 2022, the Company has 12,000,000 and 8,700,000 Public Warrants and Private Placement Warrants, respectively, outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination; provided that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Stockholders or their affiliates, without taking into account any Founder Shares held by the Initial Stockholders or such affiliates, as applicable, prior to such issuance), (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until the completion of a Business Combination, subject to certain limited exceptions. Additionally, except as set forth below, the Private Placement Warrants will be non-redeemable Redemption of warrants . • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the closing price of Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a30-tradingday

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 9 - Fair Value Measurements The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: March 31, 2023 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account—U.S. Treasury Securities $ 29,211,576 $ — $ — Liabilities: Derivative liabilities-public warrants $ — $ 151,200 $ — Derivative liabilities-private warrants $ — $ 109,640 $ — Forward Purchase Agreement liability $ — $ — $ 125,473 December 31, 2022 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account—U.S. Treasury Securities $ 244,314,622 $ — $ — Liabilities: Derivative liabilities-public warrants $ — $ 49,200 $ — Derivative liabilities-private warrants $ — $ 35,690 $ — Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement on October 1, 2021 because the Public Warrants were separately listed and traded in an active market. The estimated fair value of the Public Warrants transferred from a Level 1 measurement to a Level 2 fair value measurement in September 2022, due to the limited trading activity of the Public Warrants at September 30, 2022 through March 31, 2023. The Private Placement Warrants were transferred from a Level 3 measurement to a Level 2 measurement in September 2022, as the Public and Private Placement Warrants are viewed as economically equivalent. There were Level 1 assets include investments in money market funds and U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields and quoted market prices from dealers or brokers. The initial fair value of the Public Warrants issued in connection with the Initial Public Offering and the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Black-Scholes model at each measurement date until September 30, 2022 when the public market quoted price was used. The fair value of over-allotment option was estimated using a Black-Scholes model. For the three months ended March 31, 2023 and 2022, the Company recognized a gain to the statements of operations resulting from a increase and decrease in the fair value of liabilities of approximately $176,000 and $3.9 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. The estimated fair value of the Forward Purchase Agreement liability The initial fair value and the value as of March 31, 2023 of the Forward Purchase Agreement liability issued was estimated using a Put Option Pricing model, which that were analyzed and incorporated into the model included the put price, the risk-free rate, the variable term, the settlement features, the likelihood of completing a business combination and the early termination provisions. The model estimates the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e., stock price, exercise price, etc.). Probabilities were assigned to each variable such as the timing and pricing of events over the term of the instruments based on management projections. The fair value was adjusted for the market implied likelihood of completing a business combination. The key inputs are summarized below: Valuation Common Probability Maximum Risk Free Implied 3/29/2023 10.35 14.00 % 3.74 3.74 % 2.90 % 3/31/2023 10.22 14.00 % 3.73 3.68 % 3.50 % Description Carrying Value at Change in Fair Carrying Value at Liabilities: Forward Purchase Agreement $ 86,369 $ 39,104 $ 125,473

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 10 - Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date the condensed financial statements were issued. Based upon this review, other than noted below and as described above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. On April 3, 2023, the Company entered into a Business Combination Agreement with Avila Energy Corporation, an Alberta corporation (“Avila”), pursuant to which the Company will acquire Avila for consideration of shares of the Company following its redomicile into the Province of Alberta. The business combination agreement and related executed agreements included supporting agreements and a forward share purchase agreement are more fully described and filed with the Company’s Current Report on Form 8-K On April 18, 2022, the Company received a notification from the New York Stock Exchange (“NYSE”) that it was in violation of NYSE requirements as it had failed to timely file its Annual Report on Form 10-K 10-K”) 10-K 10-K On April 27, 2023, the Company issued a press release reporting that the Company will transfer the listing of its securities to The Nasdaq Stock Market. In the press release, the Company stated that its securities will commence trading on Nasdaq upon the market open on Tuesday, May 2, 2023. The Company’s Class A common stock will continue trading under the ticker symbol “INAQ” on the Nasdaq Global Market and the Company’s units and warrants will continue trading under the ticker symbols “INAQU” and “INAQW,” respectively, on the Nasdaq Capital Market.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form10-K filed by the Company with the SEC on April 19, 2023.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation cover a Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Use of Estimates	Use of Estimates The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income from investments held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Financial Instruments	Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” equals or approximates the carrying amounts represented in the condensed balance sheets, except for the derivative liabilities (see Note 9).
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value
Derivative Liabilities	Derivative Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants and the forward purchase agreement, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period for so long as they are outstanding. The initial fair value of the Public Warrants issued in connection with the Public Offering and the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using the public market quoted prices at each measurement date starting at June 30, 2022. The fair value of Public Warrants has subsequently been measured based on the listed market price of such warrants. Derivative warrant liabilities are classified as non-current The Company granted the underwriters a 45-day The Forward Purchased Agreement entered into on March 29, 2023 included elements that require liability classification under ASC 480. Accordingly, the Company recognizes the Forward Purchase Agreement as a liability at fair value and adjusts the carrying value of the instruments to fair value at each reporting period for so long as it is outstanding. The initial fair value and the value as of March 31, 2023 of the Forward Purchase Agreement liability issued was estimated using a Put Option Pricing model, which analyzed and incorporated into the model the put price, the risk-free rate, the variable term, the settlement features, the likelihood of completing a business combination and the early termination provisions. The model estimates the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e., stock price, exercise price, etc.). Probabilities were assigned to each variable such as the timing and pricing of events over the term of the instruments based on management projections. The fair value was adjusted for the market implied likelihood of completing a business combination.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating non-current
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were offset by a full valuation allowance as of March 31, 2023 and December 31, 2022. The Deferred tax liability as of March 31, 2023 and December 31, 2022 were zero and $156,593, respectively. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the fin a
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 2,848,607 and 24,000,000 shares of Class A common stock subject to possible redemption as of March 31, 2023 and December 31, 2022, respectively, are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A common stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in
Net Income Per Common Share	Net Income Per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. The presentation assumes a business combination as the most likely outcome. Net income per common share is calculated by dividing the net income by the weighted average shares of common stock outstanding for the respective period. The calculation of diluted net income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the private placement warrants to purchase an aggregate of 20,700,000 shares of Class A common stock in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the three months ended March 31, 2023 and 2022. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of common stock: For the Three Months Ended March 31, 2023 2022 Class A Class B Class A Class B Basic and diluted net income per common share: Numerator: Allocation of net income $ 690,336 $ 205,133 $ 2,703,598 $ 675,899 Denominator: Basic and diluted weighted average common shares outstanding 18,456,264 5,484,270 24,000,000 6,000,000 Basic and diluted net income per common share $ 0.04 $ 0.04 $ 0.11 $ 0.11
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial stateme n

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Basic and Diluted Net Income Per Common Share	The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of common stock: For the Three Months Ended March 31, 2023 2022 Class A Class B Class A Class B Basic and diluted net income per common share: Numerator: Allocation of net income $ 690,336 $ 205,133 $ 2,703,598 $ 675,899 Denominator: Basic and diluted weighted average common shares outstanding 18,456,264 5,484,270 24,000,000 6,000,000 Basic and diluted net income per common share $ 0.04 $ 0.04 $ 0.11 $ 0.11

Class A Shares of Common Stoc_2

Class A Shares of Common Stock Subject to Possible Redemption (Tables)	3 Months Ended
	Mar. 31, 2023
Temporary Equity Disclosure [Abstract]
Summary of Class A Common Stock Subject to Possible Redemption	The shares of Class A common stock issued in the Initial Public Offering were recognized in Class A common stock subject to possible redemption as follows: Gross proceeds from Initial Public Offering $ 240,000,000 Less: Fair value of Public Warrants at issuance (7,582,627 ) Offering costs allocated to Class A common stock subject to possible redemption (20,050,096 ) Plus: Accretion on Class A common stock subject to possible redemption amount 31,230,313 Class A common stock subject to possible redemption at December 31, 2022 243,597,590 Less: Redemptions (215,621,388 ) Accretion of carrying value to redemption value (3,628,151 ) Plus: Waiver of underwriting fee allocated to Class A Common Stock 5,126,890 Class A common stock subject to possible redemption at March 31, 2023 $ 29,474,941

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis	The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: March 31, 2023 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account—U.S. Treasury Securities $ 29,211,576 $ — $ — Liabilities: Derivative liabilities-public warrants $ — $ 151,200 $ — Derivative liabilities-private warrants $ — $ 109,640 $ — Forward Purchase Agreement liability $ — $ — $ 125,473 December 31, 2022 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account—U.S. Treasury Securities $ 244,314,622 $ — $ — Liabilities: Derivative liabilities-public warrants $ — $ 49,200 $ — Derivative liabilities-private warrants $ — $ 35,690 $ —
Summary of Disclosure in tabular form of significant unobservable inputs used in the measurement of forward purchase agreement liability	Valuation Common Probability Maximum Risk Free Implied 3/29/2023 10.35 14.00 % 3.74 3.74 % 2.90 % 3/31/2023 10.22 14.00 % 3.73 3.68 % 3.50 %
Summary of Key Inputs	Description Carrying Value at Change in Fair Carrying Value at Liabilities: Forward Purchase Agreement $ 86,369 $ 39,104 $ 125,473

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)						3 Months Ended		12 Months Ended
	Mar. 29, 2023	Mar. 28, 2023	Mar. 06, 2023	Sep. 13, 2021	Sep. 07, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	May 31, 2023	Aug. 16, 2022	Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Entity incorporation date of incorporation						Apr. 20, 2021
Deferred underwriting commissions						$ 6,600,000		$ 12,000,000
Payment to acquire restricted investments						$ 80,000	$ 0
Share price						$ 10.05
Restricted Investments Term					185 days
Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination						100%
Dissolution expenses						$ 100,000
Minimum share price of the residual assets remaining available for distribution						$ 10.05
Working capital deficit						$ 59,000
Stock issued during the period value issued for services						25,000
Proceeds from unsecured and non-interest bearing promissory note						$ 163,000
Repayment of note balance				$ 6,000	$ 157,000
Banking regulation, mortgage banking, net worth, minimum			$ 5,000,001
Percentage of common stock holding						65%
Temporary equity shares outstanding						2,848,607		24,000,000
Assets Held-in-trust, Noncurrent		$ 80,000				$ 29,211,576		$ 244,314,622	$ 80,000
Business Combination Date Of Consummation		May 07, 2023
Cash, cash equivalents, restricted cash, and restricted cash equivalents						$ 1,348,539	$ 569,408	171,583			$ 877,937
Inflation Reduction Act 2022 [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of excise tax on repurchase of shares										1%
Percentage of fair market value of shares repurchased at the time of repurchase on excise tax										1%
Maximum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of redeeming shares of public shares without the company's prior written consent						20%
Per share amount to be maintained in the trust account						$ 10.05
Minimum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Per share amount to be maintained in the trust account						$ 10.05
Percentage Of Fair Market Value Of Target Business To Asset Held In Trust Account						80%
Minimum [Member] | Investment Company Act of 1940 [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Equity method investment ownership percentage						50%
Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants and rights issued during the period					8,700,000	8,700,000
Class of warrants and rights issued, price per warrant					$ 1	$ 1
Proceeds from issuance of warrants					$ 8,700,000	$ 8,700,000
Sponsor [Member] | Working Capital Loans [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Working capital loans outstanding						$ 0
Sponsor [Member] | Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants and rights issued during the period					7,500,000	7,500,000
Cantor and Odeon [Member] | Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants and rights issued during the period					1,200,000	1,200,000
IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Payment to acquire restricted investments					$ 241,200,000
Share price					$ 10.05
IPO [Member] | Forward Share Purchase Agreement [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of shares purchased by investor	2,376,000
Maximum number of shares issued	2,500,000
IPO [Member] | Working Capital Loans [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Working capital loans outstanding								0
Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds From Issuance Of IPO								$ 240,000,000
Share price						$ 10.35		$ 10.15
Common stock par or stated value per share						$ 0.0001		$ 0.0001
Stock redeemed or called during period shares			21,151,393
Percentage of common stock holding			88.10%
Common stock held in trust			$ 28,744,831
Temporary equity shares issued			2,848,607
Temporary equity shares outstanding			2,848,607			2,848,607		24,000,000
Common Class A [Member] | Conversion of Class B Common stock to Class A common Stock [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock par or stated value per share			$ 0.0001
Common Class A [Member] | IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock Issued During Period Shares					24,000,000
Proceeds From Issuance Of IPO					$ 240,000,000
Offering costs					17,500,000
Deferred underwriting commissions					12,000,000
Offering costs allocated to derivative warrant liabilities					$ 668,000
Common Class B [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock par or stated value per share						$ 0.0001		$ 0.0001
Common Class B [Member] | Conversion of Class B Common stock to Class A common Stock [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock par or stated value per share			$ 0.0001

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Per Common Share (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Allocation of net income	$ 895,469	$ 3,379,497
Denominator:
Weighted Average Number of Shares Outstanding, Basic	5,484,270
Weighted Average Number of Shares Outstanding, Diluted	5,484,270
Basic net income (loss) per common share	$ 0.04
Diluted net income (loss) per common share	$ 0.04
Common Class A [Member]
Numerator:
Allocation of net income	$ 690,336	$ 2,703,598
Denominator:
Weighted Average Number of Shares Outstanding, Basic	18,456,264	24,000,000
Weighted Average Number of Shares Outstanding, Diluted	18,456,264	24,000,000
Basic net income (loss) per common share	$ 0.04	$ 0.11
Diluted net income (loss) per common share	$ 0.04	$ 0.11
Common Class B [Member]
Numerator:
Allocation of net income	$ 205,133	$ 675,899
Denominator:
Weighted Average Number of Shares Outstanding, Basic	5,484,270	6,000,000
Weighted Average Number of Shares Outstanding, Diluted	5,484,270	6,000,000
Basic net income (loss) per common share	$ 0.04	$ 0.11
Diluted net income (loss) per common share	$ 0.04	$ 0.11

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 06, 2023	Dec. 31, 2022	Sep. 07, 2021
Cash equivalents	$ 0			$ 0
FDIC insured amount	250,000
Unrecognized tax benefits	0			0
Unrecognized tax benefits, accrued for the payment of interest and penalties	$ 0			$ 0
Class A ordinary shares, shares subject to possible redemption outstanding	2,848,607			24,000,000
Term of restricted investments	185 days
Income Tax Expense (Benefit)	$ 416,252	$ 0
Deferred tax liability	$ 0	$ 156,593
Over-Allotment Option [Member]
Overallotment option vesting period	45 days
Common stock shares subscribed but not yet issued	3,600,000
Class A [Member]
Class A ordinary shares, shares subject to possible redemption outstanding	2,848,607		2,848,607	24,000,000
Number of common stock into which the class of warrant or right may be converted	20,700,000				1

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($)		3 Months Ended	12 Months Ended
	Sep. 07, 2021	Mar. 31, 2023	Dec. 31, 2022
Disclosure Of Initial Public Offering [Line Items]
Deferred underwriting commissions		$ 6,600,000	$ 12,000,000
Class A [Member]
Disclosure Of Initial Public Offering [Line Items]
Proceeds received from initial public offering, gross			$ 240,000,000
Class of warrants or rights number of shares covered by each warrants or right	1	20,700,000
Class of warrants or rights exercise price	$ 11.5
IPO [Member] | Class A [Member]
Disclosure Of Initial Public Offering [Line Items]
Stock issued during period shares	24,000,000
Proceeds received from initial public offering, gross	$ 240,000,000
Offering costs	17,500,000
Deferred underwriting commissions	12,000,000
Offering costs allocated to derivative warrant liabilities	$ 668,000
Over-Allotment Option [Member]
Disclosure Of Initial Public Offering [Line Items]
Overallotment option vesting period		45 days
Common stock shares subscribed but not yet issued		3,600,000
Anchor Investor [Member] | IPO [Member]
Disclosure Of Initial Public Offering [Line Items]
Stock issued during period shares	24,000,000
Number of shares purchased by investor	23,760,000
Anchor Investor [Member] | Founder Shares [Member]
Disclosure Of Initial Public Offering [Line Items]
Esimated fair value of shares sold to investor	$ 3,200,000
Estimated fair value of shares sold to investors price per share	$ 2.37
Anchor Investor [Member] | Founder Shares [Member] | Sponsor [Member]
Disclosure Of Initial Public Offering [Line Items]
Aggregate number of shares transferred to investor	1,350,000
Price per founder share	$ 0.004

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)							3 Months Ended
	Oct. 16, 2021	Sep. 13, 2021	Sep. 07, 2021	Sep. 01, 2021	Jul. 29, 2021	May 05, 2021	Mar. 31, 2023	Mar. 31, 2022	May 31, 2023	Dec. 31, 2022	Apr. 30, 2021
Related Party Transaction [Line Items]
Issuance of ordinary shares to sponsor value							$ 25,000
Share price							$ 10.05
Contributed from Sponsor							$ 100,000	$ 0
Service Agreement [Member]
Related Party Transaction [Line Items]
Due to related parties							30,000			$ 40,000
Related party transaction fees payable per month							$ 30,000	30,000
Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrants and rights issued during the period			8,700,000				8,700,000
Class of warrants and rights issued, price per warrant			$ 1				$ 1
Proceeds from issuance of warrants			$ 8,700,000				$ 8,700,000
Class of warrants or rights exercise price							$ 11.5
Period to exercise warrants after business combination							30 days
Sponsor [Member]
Related Party Transaction [Line Items]
Contributed from Sponsor							$ 100,000
Sponsor [Member] | Service Agreement [Member]
Related Party Transaction [Line Items]
Due to related parties							45,000			$ 45,000
Related party transaction fees payable per month							45,000	$ 45,000
Sponsor [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Debt instrument face value											$ 300,000
Proceeds from related party debt							163,000
Repayments of related party debt		$ 6,000	$ 157,000
Sponsor [Member] | Working Capital Loans [Member]
Related Party Transaction [Line Items]
Working capital loans convertible into warrants							$ 1,500,000
Debt instrument conversion price per warrant							$ 1
Sponsor [Member] | Office Space, Secretarial and Administrative Services [Member]
Related Party Transaction [Line Items]
Related party transaction fees payable per month				$ 10,000
Sponsor [Member] | Service Fee [Member]
Related Party Transaction [Line Items]
Related party transaction fees payable per month				$ 15,000
Sponsor [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrants and rights issued during the period			7,500,000				7,500,000
Cantor and Odeon [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrants and rights issued during the period			1,200,000				1,200,000
Class B [Member]
Related Party Transaction [Line Items]
Common stock par or stated value per share							$ 0.0001			$ 0.0001
Common stock shares outstanding							900,000		900,000	6,000,000
Forfeiture Of Founder Shares In Shares	900,000
Class B [Member] | Founder [Member]
Related Party Transaction [Line Items]
Issuance of ordinary shares to sponsor shares						6,181,250
Issuance of ordinary shares to sponsor value						$ 25,000
Common stock par or stated value per share						$ 0.0001
Common stock shares outstanding					6,900,000
Founder shares transferred during period shares							1,350,000
Founder shares as a percentage of issued and outstanding shares after initial public offering							20%
Stock split ratio					1.1162791
Class B [Member] | Founder [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Common stock shares subject to forfeiture							900,000
Class A [Member]
Related Party Transaction [Line Items]
Common stock par or stated value per share							$ 0.0001			$ 0.0001
Common stock shares outstanding							7,948,607			24,000,000
Share price							$ 10.35			$ 10.15
Class of warrants or rights exercise price			$ 11.5
Class A [Member] | Founder [Member] | Restriction On Transfer Of Sponsor Shares [Member]
Related Party Transaction [Line Items]
Lock in period of shares							1 year
Share price							$ 12
Waiting period after which the share trading days are considered							150 days
Number of trading days for determining share price							20 days
Number of consecutive trading days for determining the share price							30 days

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)			3 Months Ended
	Mar. 29, 2023	Mar. 28, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Sep. 07, 2021
Other Commitments [Line Items]
Waiver of Underwriting Commissions		$ 5,400,000
Deferred Underwriting Commissions		8,400,000
Reminder of deferred underwriting commissions		3,000,000
Deferred Underwriting Commissions Noncurrent			$ 6,600,000		$ 12,000,000
Gain on forgiveness of deferred underwriting fee payable		273,110	273,110	$ 57,679
Class A [Member]
Other Commitments [Line Items]
Underwriting Fee Waived		$ 5,126,890	$ 5,126,890
Class A [Member] | IPO [Member]
Other Commitments [Line Items]
Deferred Underwriting Commissions Noncurrent						$ 12,000,000
Underwriting Agreement [Member]
Other Commitments [Line Items]
Underwriting discount per unit			$ 0.2
Underwriting discount payable			$ 4,800,000
Deferred underwriting commission payable per unit			$ 0.5
Deferred underwriting commission payable non current			$ 12,000,000
Additional deferred underwriting commission payable per unit			$ 0.7
Additional deferred underwriting commission payable non current			$ 2,500,000
Deferred underwriting commission payable including additional commission			$ 14,500,000
Forward Share Purchase Agreement [Member] | IPO [Member]
Other Commitments [Line Items]
Number of shares purchased by investor	2,376,000
Maximum number of shares issued	2,500,000

Class A Shares of Common Stoc_3

Class A Shares of Common Stock Subject to Possible Redemption - Summary of Class A Common Stock Subject to Possible Redemption (Detail) - USD ($)		3 Months Ended	12 Months Ended
	Mar. 28, 2023	Mar. 31, 2023	Dec. 31, 2022
Plus:
Accrestion of common stock subject to possible redemption		$ 3,628,151
Common Class A [Member]
Temporary Equity [Line Items]
Gross proceeds from Initial Public Offering			$ 240,000,000
Less:
Fair value of Public Warrants at issuance			(7,582,627)
Offering costs allocated to Class A common stock subject to possible redemption			(20,050,096)
Redemptions		(215,621,388)
Accretion of carrying value to redemption value		(3,628,151)
Plus:
Accrestion of common stock subject to possible redemption			31,230,313
Waiver of underwriting fee allocated to Class A Common Stock	$ 5,126,890	5,126,890
Class A common stock subject to possible redemption		$ 29,474,941	$ 243,597,590

Class A Shares of Common Stoc_4

Class A Shares of Common Stock Subject to Possible Redemption - Additional Information (Detail) - USD ($)	Mar. 06, 2023	Mar. 31, 2023	Dec. 31, 2022
Temporary Equity [Line Items]
Temporary equity, par value		$ 0.0001
Temporary equity shares outstanding		2,848,607	24,000,000
Percentage of common stock holding		65%
Common Class A [Member]
Temporary Equity [Line Items]
Temporary equity shares authorized		200,000,000
Temporary equity shares outstanding	2,848,607	2,848,607	24,000,000
Stock redeemed or called during period shares	21,151,393
Percentage of common stock holding	88.10%
Temporary equity, redemption price per share		$ 10.25	$ 10.15
Common stock held in trust	$ 28,744,831

Stockholders' Deficit - Additio

Stockholders' Deficit - Additional Information (Detail) - $ / shares		3 Months Ended
	Mar. 22, 2023	Mar. 31, 2023	May 31, 2023	Dec. 31, 2022
Class of Stock [Line Items]
Preferred stock shares authorized		1,000,000		1,000,000
Preferred stock par or stated value per share		$ 0.0001		$ 0.0001
Preferred stock shares issued		0		0
Preferred stock shares outstanding		0		0
Class A [Member]
Class of Stock [Line Items]
Common stock shares authorized		200,000,000		200,000,000
Common stock par or stated value per share		$ 0.0001		$ 0.0001
Common stock shares issued		7,948,607		24,000,000
Common stock shares outstanding		7,948,607		24,000,000
Common stock, Voting rights		one
Class B [Member]
Class of Stock [Line Items]
Common stock shares authorized		20,000,000		20,000,000
Common stock par or stated value per share		$ 0.0001		$ 0.0001
Common stock shares issued		900,000		6,000,000
Common stock shares outstanding		900,000	900,000	6,000,000
Common stock, Voting rights		one
Conversion of stock shares issued	5,100,000
Class B [Member] | Maximum [Member]
Class of Stock [Line Items]
Percentage of common stock shares that could be issued to the initial stockholders		20%

Warrants - Additional Informati

Warrants - Additional Information (Detail) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Public Warrants [Member]
Disclosure Of Warrants [Line Items]
Class of warrants or rights outstanding	12,000,000
Class of warrants or rights number of days after which the warrants are excercisable from the date of consummation of business combination	30 days
Class of warrants or rights number of days within which the securities issuable upon exercise of warrants shall be registered	15 days
Class of warrants or rights number of days within which the securities issuable upon exercise of warrants whose registration shall become effective	60 days
Class of warrants or rights exercise price	$ 11.5
Class of warrants or rights term	5 years
Public Warrants [Member] | Event Triggering Adjustment To The Redemption Price Of Warrants [Member] | As A Percentage Of Market Value [Member]
Disclosure Of Warrants [Line Items]
Warrant redemption price per share percentage	180%
Public Warrants [Member] | Event Triggering Adjustment To The Redemption Price Of Warrants [Member] | As A Percentage Of Newly Issued Price [Member]
Disclosure Of Warrants [Line Items]
Adjusted exercise price of warrants as a percentage of newly issued price	115%
Public Warrants [Member] | Conditions Determining The Redemption Of Warrants [Member]
Disclosure Of Warrants [Line Items]
Redemption trigger price of share	$ 18
Class of warrants or rights redemption price per unit of warrant	$ 0.01
Minimum notice period to be given to warrant holders prior to warrant redemption	30 days
Number of trading days for determining the redemption trigger price of share	20 days
Number of consecutive trading days for determining the redemption trigger price of share	30 days
Public Warrants [Member] | Maximum [Member] | Event Triggering Adjustment To The Exercise Price Of Warrants [Member]
Disclosure Of Warrants [Line Items]
Shares issued price per share	$ 9.2
Public Warrants [Member] | Minimum [Member] | Event Triggering Adjustment To The Exercise Price Of Warrants [Member]
Disclosure Of Warrants [Line Items]
Percentage of the proceeds to be used for business combination	60%
Private Placement Warrants [Member]
Disclosure Of Warrants [Line Items]
Class of warrants or rights outstanding		8,700,000
Class of warrants or rights exercise price	$ 11.5

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Change in fair value of derivative warrant liabilities	$ 175,950	$ (3,899,070)
Derivative Warrant Liabilities [Member]
Change in fair value of derivative warrant liabilities	176,000	$ 3,900,000
Transfers between levels	$ 0

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis (Detail) - USD ($)	May 31, 2023	Mar. 31, 2023	Mar. 28, 2023	Dec. 31, 2022
Assets:
Assets Held-in-trust, Noncurrent	$ 80,000	$ 29,211,576	$ 80,000	$ 244,314,622
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Forward Purchase Agreement Liability [Member]
Liabilities:
Derivative Liability		125,473
Fair Value, Recurring [Member] | US Treasury Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Assets:
Assets Held-in-trust, Noncurrent		29,211,576		244,314,622
Fair Value, Recurring [Member] | Public Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Liabilities:
Derivative Liability		151,200		49,200
Fair Value, Recurring [Member] | Private Placement Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Liabilities:
Derivative Liability		$ 109,640		$ 35,690

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability (Detail) - Forward Purchase Agreement Liability [Member]	Mar. 31, 2023 yr $ / shares	Mar. 29, 2023 yr $ / shares
Common Stock Price [Member] | Valuation Date One [Member]
Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability [Line Items]
Derivative Liability, Measurement Input | $ / shares		10.35
Common Stock Price [Member] | Valuation Date Two [Member]
Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability [Line Items]
Derivative Liability, Measurement Input | $ / shares	10.22
Probability of completing BC [Member] | Valuation Date One [Member]
Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability [Line Items]
Derivative Liability, Measurement Input		14
Probability of completing BC [Member] | Valuation Date Two [Member]
Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability [Line Items]
Derivative Liability, Measurement Input	14
Maximum Term yrs [Member] | Valuation Date One [Member]
Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability [Line Items]
Derivative Liability, Measurement Input | yr		3.74
Maximum Term yrs [Member] | Valuation Date Two [Member]
Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability [Line Items]
Derivative Liability, Measurement Input | yr	3.73
Risk-free rate [Member] | Valuation Date One [Member]
Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability [Line Items]
Derivative Liability, Measurement Input		3.74
Risk-free rate [Member] | Valuation Date Two [Member]
Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability [Line Items]
Derivative Liability, Measurement Input	3.68
Volatility [Member] | Valuation Date One [Member]
Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability [Line Items]
Derivative Liability, Measurement Input		2.9
Volatility [Member] | Valuation Date Two [Member]
Disclosure in Tabular form of Significant Unobservable Inputs Used in the Measurement of Forward Purchase Agreement Liability [Line Items]
Derivative Liability, Measurement Input	3.5

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Key Inputs (Detail) - Forward Purchase Agreement Liability [Member] - USD ($)		3 Months Ended
	Mar. 29, 2023	Mar. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Carrying Value at March 29, 2023	$ 86,369
Change in Fair value		$ 39,104
Carrying Value at March 31, 2023		$ 125,473